NFKB1 and glioblastoma: It is suggested that H2A.J may act similarly as in glioblastoma through upregulating IL-6/STAT signaling, EMT signaling and TNF-α/NF-κB pathways to control inflammatory response, cell proliferation, migration, anti-apoptosis, and survival response (Figure 6) [203].